Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Daniel J Herr"'
Publikováno v:
Frontiers in Neurology, Vol 6 (2015)
Ischemia-reperfusion (IR) injury comprises a significant portion of morbidity and mortality from heart and brain diseases worldwide. This enduring clinical problem has inspired myriad reports in the scientific literature of experimental interventions
Externí odkaz:
https://doaj.org/article/6f7f84c314104737ae92fc352e5590eb
Autor:
Kyle C. Cuneo, Daniel J. Herr
Publikováno v:
Surgical Oncology Clinics of North America. 32:415-432
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bc4488a72cc205e649745616ea43309
https://doi.org/10.1016/j.soc.2023.02.002
https://doi.org/10.1016/j.soc.2023.02.002
Autor:
Daniel J. Herr, Huiying Yin, Steven G. Allen, Derek Bergsma, Aleksandar F. Dragovic, Robert T. Dess, Martha Matuszak, Margaret Grubb, Michael Dominello, Benjamin Movsas, Larry L. Kestin, James A. Hayman, Peter Paximadis, Matthew Schipper, Shruti Jolly
Publikováno v:
Practical Radiation Oncology. 13:e254-e260
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6af56ccbce4e1e04b4492b89de9b7dc6
https://doi.org/10.1016/j.prro.2023.01.010
https://doi.org/10.1016/j.prro.2023.01.010
Autor:
Matthew M. Cousins, Chuck Mayo, Theresa Devasia, Michael Dykstra, Samuel Regan, Sean Miller, Steven G. Allen, Alex K. Bryant, Krystal Morales-Rivera, Daniel J. Herr, Donna M. Edwards, Jamie Takayesu, Samuel Birer, Nancy Egerer, Joseph Evans, David Elliott, Caitlin Henderson, Anna M. Laucis, Matthew McFarlane, Aleksandar F. Dragovic, Jennifer Shah, James A. Hayman, Lara N. Coughlin, Mark Ilgen, Reshma Jagsi
Publikováno v:
Practical radiation oncology.
Cannabis use rates are increasing in the United States. Patients with cancer use cannabis for many reasons, even without high-quality supporting data. This study sought to characterize cannabis use among patients seen in radiation oncology in a state
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7a556e410f1397a3bd480091b8035d1
https://pubmed.ncbi.nlm.nih.gov/36460181
https://pubmed.ncbi.nlm.nih.gov/36460181
Autor:
Daniel J. Herr, Chang Wang, Mishal Mendiratta-Lala, Martha Matuszak, Charles S. Mayo, Yue Cao, Neehar Parikh, Randy Ten Hanken, Dawn Owen, Teodor Stanescu, Michael Yan, Laura A. Dawson, Matthew Schipper, Theodore S. Lawrence, Kyle C. Cuneo
Publikováno v:
Cancer Research. 83:CT151-CT151
Introduction: Stereotactic body radiation therapy (SBRT) for the treatment of hepatocellular carcinoma (HCC) remains a challenge due to high rates of toxicity in patients with impaired liver function or tumors not amenable to thermal ablation. We per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6b873eeaf9ae9ee61b4995df705f162
https://doi.org/10.1158/1538-7445.am2023-ct151
https://doi.org/10.1158/1538-7445.am2023-ct151
Autor:
Daniel J. Herr, Kim A. Hochstedler, Huiying Yin, Robert T. Dess, Martha Matuszak, Margaret Grubb, Michael Dominello, Benjamin Movsas, Larry L. Kestin, Derek Bergsma, Aleksandar F. Dragovic, Inga S. Grills, James A. Hayman, Peter Paximadis, Matthew Schipper, Shruti Jolly
Publikováno v:
Practical radiation oncology. 12(5)
Cardiac radiation exposure is associated with an increased rate of adverse cardiac events in patients receiving radiation therapy for locally advanced non-small cell lung carcinoma (NSCLC). Previous analysis of practice patterns within the Michigan R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a2a1df63b6bba9f1b25fbc8c29a707b
https://pubmed.ncbi.nlm.nih.gov/35121192
https://pubmed.ncbi.nlm.nih.gov/35121192
Autor:
Amir Zahra, Daniel J. Herr, Bryan G. Allen, Anand K. Sharma, Sarah L. Mott, Nicholas S. Andresen, Coyt R. Rountree, John M. Buatti, Jacy O’Keefe, John M. Watkins, J. Kyle Russo
Publikováno v:
Rep Pract Oncol Radiother
Background Concurrent chemoradiotherapy (CCRT) is commonly employed in limited-stage small-cell lung cancer (LS-SCLC); however, the optimal radiotherapy regimen is still unknown. This 3-institution analysis compares long-term disease control and surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a98a2757368b5c291367e89226cddd
https://europepmc.org/articles/PMC7251533/
https://europepmc.org/articles/PMC7251533/
Autor:
Lauren E. Ball, Daniel J. Herr, James C. Chou, Mauhamad Baarine, John J. Lemasters, Craig Beeson, Sverre E. Aune, Donald R. Menick, Xiaoyang Li
Publikováno v:
Journal of Molecular and Cellular Cardiology. 114:309-319
Rationale Recent evidence indicates that histone deacetylase enzymes (HDACs) contribute to ischemia reperfusion (I/R) injury, and pan-HDAC inhibitors have been shown to be cardioprotective when administered either before an ischemic insult or during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97c88e31808fca3aad736ff870007dd7
https://doi.org/10.1016/j.yjmcc.2017.12.004
https://doi.org/10.1016/j.yjmcc.2017.12.004
Publikováno v:
Biochim Biophys Acta Mol Basis Dis
Ischemia reperfusion injury (I/R injury) contributes significantly to morbidity and mortality following myocardial infarction (MI). Although rapid reperfusion of the ischemic myocardium was established decades ago as a highly beneficial therapy for M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f59ac12b213dd4fbf0d8b04e412142d
https://pubmed.ncbi.nlm.nih.gov/32068115
https://pubmed.ncbi.nlm.nih.gov/32068115
Publikováno v:
JCI Insight, Vol 3, Iss 4 (2018)
Myocardial infarctions (MIs) cause the loss of myocytes due to lack of sufficient oxygenation and latent revascularization. Although the administration of histone deacetylase (HDAC) inhibitors reduces the size of infarctions and improves cardiac phys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::008a2c196662d06789cd6ad3df3072f5
https://doaj.org/article/044520e049434ae2b0edfb80f6a25386
https://doaj.org/article/044520e049434ae2b0edfb80f6a25386